Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Anika Therapeutics (ANIK) Debt Ratio (2020 - 2022)

Anika Therapeutics has reported Debt Ratio over the past 7 years, most recently at 0.01 for Q2 2022.

  • Quarterly Debt Ratio fell 73.77% to 0.01 in Q2 2022 from the year-ago period, while the trailing twelve-month figure was 0.01 through Jun 2022, down 73.77% year-over-year, with the annual reading at 0.01 for FY2021, 65.32% down from the prior year.
  • Debt Ratio was 0.01 for Q2 2022 at Anika Therapeutics, down from 0.01 in the prior quarter.
  • Over five years, Debt Ratio peaked at 0.11 in Q2 2020 and troughed at 0.01 in Q3 2021.
  • The 3-year median for Debt Ratio is 0.04 (2020), against an average of 0.04.
  • Year-over-year, Debt Ratio tumbled 59.07% in 2021 and then plummeted 81.67% in 2022.
  • A 3-year view of Debt Ratio shows it stood at 0.04 in 2020, then plummeted by 65.32% to 0.01 in 2021, then fell by 1.86% to 0.01 in 2022.
  • Per Business Quant, the three most recent readings for ANIK's Debt Ratio are 0.01 (Q2 2022), 0.01 (Q1 2022), and 0.01 (Q4 2021).